Rifampin
Showing 1 - 25 of 564
Healthy Trial in Québec (Camlipixant + Rifampin, Camlipixant + Rabeprazole)
Not yet recruiting
- Healthy
- Camlipixant + Rifampin
- Camlipixant + Rabeprazole
-
Québec, Quebec, CanadaSyneos Health
Jun 2, 2023
Genetic Determinants of Clindamycin/Rifampin Interaction
Completed
- VA Drug Interaction
-
Paris, FranceGroupe Hospitalier Diaconesses Croix Saint Simon
Oct 24, 2022
Healthy Volunteers Trial in Changchun (Larotinib, Rifampin, Itraconazole)
Active, not recruiting
- Healthy Volunteers
- Larotinib
- +2 more
-
Changchun, Jilin, ChinaFirst Hospital of Jilin University
Oct 26, 2022
Healthy Participants Trial in Madison (AMG 510, Rifampin)
Completed
- Healthy Participants
- AMG 510
- Rifampin
-
Madison, WisconsinCovance Clinical Research Unit, Inc 3402 Kinsman Boulevard
Oct 10, 2022
COVID-19 Pneumonia Trial in Hangzhou (STI-1558, Itraconazole, Rifampin)
Not yet recruiting
- COVID-19 Pneumonia
- STI-1558
- +2 more
-
Hangzhou, Zhejiang, ChinaZhejiang Xiaoshan Hospital
Jan 5, 2023
Relapsed or Refractory Lymphoma Trial in Austin (HMPL-523, Itraconazole, Rifampin)
Active, not recruiting
- Relapsed or Refractory Lymphoma
- HMPL-523
- +2 more
-
Austin, TexasPPD Austin
Jan 31, 2023
Healthy Volunteers Trial (CC-92480, Rifampin, Itraconazole)
Recruiting
- Healthy Volunteers
- CC-92480
- +4 more
-
Dallas, TexasCovance Clinical Research Unit - Dallas
Oct 25, 2022
Adequacy of New Pediatric Isoniazid/Rifampin/Pyrazinamide Tablet
Recruiting
- Tuberculosis
- +2 more
- Observational PK study
-
Kumasi, GhanaKwame Nkrumah University of Science and Technology
Dec 21, 2022
Relapsed or Refractory Lymphoma Trial in Miami (Itraconazole 200 mg, Fluconazole 400 mg, Rifampin 600 mg)
Completed
- Relapsed or Refractory Lymphoma
- Itraconazole 200 mg
- +3 more
-
Miami, FloridaQPS- Miami
Jan 12, 2023
Healthy Participants Trial in Salt Lake City (BMS-986235 (Treatment A), Rifampin (Treatment B))
Withdrawn
- Healthy Participants
- BMS-986235 (Treatment A)
- Rifampin (Treatment B)
-
Salt Lake City, UtahLocal Institution
Mar 17, 2022
Healthy Participants Trial in Austin (Vonoprazan, Rifampin)
Withdrawn
- Healthy Participants
- Vonoprazan
- Rifampin
-
Austin, TexasPPD Development, LP, 7551 Metro Center Drive, Suite 200
Feb 10, 2022
Healthy Person Trial in Suzhou (Orelabrutinib + Rifampin, Orelabrutinib + Itraconazole)
Completed
- Healthy Person
- Orelabrutinib + Rifampin
- Orelabrutinib + Itraconazole
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Jul 5, 2022
Drug Drug Interaction Trial in Chengdu (SPH3127 tablet, Itraconazole, Rifampin)
Completed
- Drug Drug Interaction
- SPH3127 tablet
- +2 more
-
Chengdu, Sichuan, ChinaWest China Second University Hospital, Sichuan University
Jul 28, 2022
Healthy Volunteers Trial in Daytona Beach (LOXO-305, Itraconazole, Rifampin)
Completed
- Healthy Volunteers
- LOXO-305
- +2 more
-
Daytona Beach, FloridaCovance Clinical Research Unit
Nov 23, 2021
Drug-drug Interaction Trial in San Francisco (rifampin IV, Rifadin 300Mg Capsule, Fluvastatin 20 MG)
Completed
- Drug-drug Interaction
- rifampin IV
- +2 more
-
San Francisco, CaliforniaUniversity of California San Francisco
Aug 12, 2021
Tuberculosis, Latent Tuberculosis Trial in Shanghai (Rifampin and Isoniazid, isoniazid and rifapentine)
Not yet recruiting
- Tuberculosis
- Latent Tuberculosis
- Rifampin and Isoniazid
- isoniazid and rifapentine
-
Shanghai, Shanghai, ChinaCentral Hospital of Jingan District
Aug 28, 2023
Healthy Adults Trial in Dallas (Sitravatinib 50 mg, Sitravatinib 100 mg, Itraconazole)
Recruiting
- Healthy Adults
- Sitravatinib 50 mg
- +3 more
-
Dallas, TexasLabcorp Drug Development Clinical Research Unit
Feb 23, 2022